Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.36 Million AUD | 188.85% |
| 2022 | 473.42 Thousand AUD | 103.31% |
| 2021 | 232.86 Thousand AUD | 13.2% |
| 2020 | 205.71 Thousand AUD | -49.93% |
| 2019 | 410.85 Thousand AUD | 114.57% |
| 2018 | 191.47 Thousand AUD | 852.53% |
| 2017 | 20.1 Thousand AUD | 167416.67% |
| 2016 | 12.00 AUD | -99.78% |
| 2015 | 5492.60 AUD | -10.11% |
| 2014 | 6110.25 AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 FY | 1.36 Million AUD | 188.85% |
| 2023 Q2 | 345 Thousand AUD | 0.0% |
| 2023 Q1 | 345 Thousand AUD | -75.4% |
| 2023 Q4 | 2.14 Million AUD | 0.0% |
| 2023 Q3 | 2.14 Million AUD | 520.39% |
| 2022 Q4 | 1.4 Million AUD | 0.0% |
| 2022 FY | 473.42 Thousand AUD | 103.31% |
| 2022 Q3 | 1.4 Million AUD | 955.52% |
| 2022 Q2 | 132.88 Thousand AUD | -0.0% |
| 2022 Q1 | 132.88 Thousand AUD | 255.47% |
| 2021 Q3 | 37.38 Thousand AUD | -97.31% |
| 2021 Q4 | 37.38 Thousand AUD | 0.0% |
| 2021 FY | 232.86 Thousand AUD | 13.2% |
| 2021 Q2 | 1.39 Million AUD | 0.0% |
| 2021 Q1 | 1.39 Million AUD | 623.56% |
| 2020 Q1 | 1.15 Million AUD | 1651.47% |
| 2020 Q2 | 1.15 Million AUD | 0.0% |
| 2020 Q4 | 192.16 Thousand AUD | 0.0% |
| 2020 FY | 205.71 Thousand AUD | -49.93% |
| 2020 Q3 | 192.16 Thousand AUD | -83.38% |
| 2019 Q1 | 1.17 Million AUD | 1867.03% |
| 2019 FY | 410.85 Thousand AUD | 114.57% |
| 2019 Q3 | 66.02 Thousand AUD | -94.4% |
| 2019 Q2 | 1.17 Million AUD | 0.0% |
| 2019 Q4 | 66.02 Thousand AUD | 0.0% |
| 2018 Q2 | 125.8 Thousand AUD | -0.0% |
| 2018 FY | 191.47 Thousand AUD | 852.53% |
| 2018 Q3 | 59.93 Thousand AUD | -52.36% |
| 2018 Q1 | 125.8 Thousand AUD | 156.53% |
| 2018 Q4 | 59.93 Thousand AUD | 0.0% |
| 2017 FY | 20.1 Thousand AUD | 167416.67% |
| 2017 Q3 | 49.04 Thousand AUD | -59.3% |
| 2017 Q4 | 49.04 Thousand AUD | 0.0% |
| 2017 Q2 | 120.48 Thousand AUD | 0.0% |
| 2017 Q1 | 120.48 Thousand AUD | 0.0% |
| 2016 FY | 12.00 AUD | -99.78% |
| 2015 FY | 5492.60 AUD | -10.11% |
| 2014 FY | 6110.25 AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -49.778% |
| Arrayit Corporation | 4.37 Million USD | 68.76% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 94.712% |
| Bioqual, Inc. | 58.59 Million USD | 97.666% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 91.06% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.981% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 78.52% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -30.039% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 96.6% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -205.582% |
| InVitro International | 792.62 Thousand USD | -72.524% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 87.715% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 81.071% |
| NovelStem International Corp. | 12 Thousand USD | -11295.642% |
| Optigenex Inc. | 465.97 Thousand USD | -193.469% |
| PharmChem, Inc. | 6.01 Million USD | 77.256% |
| Proteome Sciences plc | 6.4 Million USD | 78.635% |
| Response Genetics, Inc | 18.04 Million USD | 92.42% |
| Rennova Health, Inc. | 13.03 Million USD | 89.51% |
| RushNet, Inc. | 1.78 Million USD | 23.514% |
| ScreenPro Security Inc. | 1.91 Million USD | 28.558% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 63.967% |
| Todos Medical Ltd. | 7.69 Million USD | 82.229% |